1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United Kingdom >
  6. Sinclair Pharmaceuticals >
  7. M&A

Sinclair Pharmaceuticals Mergers & Acquisitions

Sinclair Pharmaceuticals M&A Summary

Sinclair Pharmaceuticals has acquired 3 companies of its own, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms.

Sinclair Pharmaceuticals’ largest acquisition to date was in 2006, when it acquired Ashbourne Pharmaceuticals for $2M. Sinclair Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include medical products (67%) and life science (34%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Sinclair Pharmaceuticals Ltd.

1st Floor Whitfield Court, 30-32 Whitfield Street,
London, W1T 2RQ
United Kingdom,
+44 20 7467 6920
www.sinclairispharma.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-02-04 Viora · Medical Products
New York, New York · www.vioramed.com

Viora is an operator of aesthetic solutions brands that treat a full range of aesthetic needs. With a wide array of worldwide certifications for our devices, manufacturing, and business operations (Medical ISO, CE, FDA, CFDA, KFDA, TFDA, Health Canada, Thai FDA, HAS, TGA, and more). Viora’s advanced, non-invasive products include the most advanced devices incorporating Laser, IPL, and proprietary RF technologies. Viora is based in New York City.

- Add-on Acquisition

Sinclair Pharmaceuticals Ltd.

-

Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal